Clinical Trial Update: A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating combination therapies with Viagenpumatucel-L (HS-110) in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Viagenpumatucel-L (HS-110) (Viagenpumatucel-L)

Snippet

Sponsor: Heat Biologics | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-09-21